N.L. Reinsmoen
- Transplantation top 0.5%
- Surgery top 10%
- Immunology top 10%
- Nephrology top 5%
- Epidemiology
- Co-authors
- Anna Y. KucheryavayaJ. Michael CeckaMary S. LeffellAshley VoAlice PengMieko ToyodaMark HaasJoseph Kahwaji
- Topics
- Renal Transplantation Outcomes and Treatments (26 papers)Transplantation: Methods and Outcomes (20 papers)Organ Transplantation Techniques and Outcomes (13 papers)
- Cited by
- TransplantationNephrologyImmunology
- Partner nations
- United StatesCanadaFrance
In The Last Decade
N.L. Reinsmoen
47 papers receiving 817 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Transplantation 534
- Surgery 399
- Immunology 263
- Nephrology 131
- Epidemiology 106
Countries citing papers authored by N.L. Reinsmoen
This map shows the geographic impact of N.L. Reinsmoen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.L. Reinsmoen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.L. Reinsmoen more than expected).
Fields of papers citing papers by N.L. Reinsmoen
This network shows the impact of papers produced by N.L. Reinsmoen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.L. Reinsmoen. The network helps show where N.L. Reinsmoen may publish in the future.
Co-authorship network of co-authors of N.L. Reinsmoen
This figure shows the co-authorship network connecting the top 25 collaborators of N.L. Reinsmoen. A scholar is included among the top collaborators of N.L. Reinsmoen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N.L. Reinsmoen. N.L. Reinsmoen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Assessment of Tocilizumab (Anti–Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipientsbreakdown → | 245 |
| 2 | 43 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 23 | |
| 7 | 127 | |
| 8 | 12 | |
| 9 | 42 | |
| 10 | 31 | |
| 11 | 53 | |
| 12 | 5 | |
| 13 | 8 | |
| 14 | 1 | |
| 15 | 2 | |
| 16 | 10 | |
| 17 | 15 | |
| 18 | Immune factors correlating with improved long-term graft outcome in kidney, lung, and heart transplants. | 9 |
| 19 | Acquired donor-specific hyporesponsiveness in long-term kidney allograft recipients. | 8 |
| 20 | 34 |
About N.L. Reinsmoen
N.L. Reinsmoen is a scholar working on Transplantation, Immunology and Surgery, having authored 47 papers that have together received 837 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (26 papers), Transplantation: Methods and Outcomes (20 papers) and Organ Transplantation Techniques and Outcomes (13 papers). The work is most often cited by research in Transplantation (534 citations), Nephrology (131 citations) and Immunology (263 citations). N.L. Reinsmoen has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Anna Y. Kucheryavaya, J. Michael Cecka, Mary S. Leffell, Ashley Vo, Alice Peng, Mieko Toyoda, Mark Haas, Joseph Kahwaji, A. Loupy and Jua Choi. Their work appears in journals such as The Journal of Immunology, Transplantation and American Journal of Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.